Technical Analysis for VRML - Vermillion, Inc.

Grade Last Price % Change Price Change
grade F 0.5827 -8.95% -0.06
VRML closed down 8.95 percent on Tuesday, September 17, 2019, on 43 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical VRML trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
20 DMA Support Bullish 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
New Downtrend Bearish -8.95%
20 DMA Support Bullish -8.95%
Hammer Candlestick Bullish -8.95%
Pocket Pivot Bullish Swing Setup -8.95%
Wide Bands Range Expansion -8.95%
NR7 Range Contraction -8.22%

Older signals for VRML ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Vermillion, Inc., together with its subsidiaries, engages in the discovery, development, and commercialization of diagnostic tests that help physicians diagnose, treat, and enhance outcomes for patients. The company develops diagnostic tests in the fields of oncology, cardiology, and women's health. Its lead product is OVA1, an ovarian cancer blood test for pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. The company is also involved in developing various programs in other clinical aspects of ovarian cancer, as well as in peripheral arterial disease. Vermillion, Inc. has strategic alliance agreement with Quest Diagnostics Incorporated to develop and commercialize diagnostic tests. It serves clinical reference laboratories, hospital laboratories, and physician offices. The company was formerly known as Ciphergen Biosystems, Inc. and changed its name to Vermillion, Inc. in August 2007. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.
Medicine Health Medical Specialties Oncology New Jersey Ovarian Cancer Diagnostic Tests Corning Inc. Peripheral Arterial Disease Gynaecological Cancer Quest Diagnostics
Is VRML a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.57
52 Week Low 0.27
Average Volume 199,060
200-Day Moving Average 0.8555
50-Day Moving Average 0.6659
20-Day Moving Average 0.5745
10-Day Moving Average 0.6285
Average True Range 0.0748
ADX 25.47
+DI 13.9497
-DI 16.2253
Chandelier Exit (Long, 3 ATRs ) 0.4748
Chandelier Exit (Short, 3 ATRs ) 0.7045
Upper Bollinger Band 0.6975
Lower Bollinger Band 0.4515
Percent B (%b) 0.53
BandWidth 42.819843
MACD Line -0.0048
MACD Signal Line -0.0187
MACD Histogram 0.0139
Fundamentals Value
Market Cap 32.72 Million
Num Shares 56.2 Million
EPS -0.22
Price-to-Earnings (P/E) Ratio -2.65
Price-to-Sales 25.03
Price-to-Book 16.79
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.68
Resistance 3 (R3) 0.69 0.66 0.66
Resistance 2 (R2) 0.66 0.64 0.66 0.66
Resistance 1 (R1) 0.62 0.62 0.61 0.62 0.65
Pivot Point 0.60 0.60 0.59 0.59 0.60
Support 1 (S1) 0.56 0.57 0.54 0.55 0.51
Support 2 (S2) 0.53 0.56 0.53 0.51
Support 3 (S3) 0.49 0.53 0.50
Support 4 (S4) 0.49